FDA notifications.  FDA grants approval of generic lamivudine tablets.
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D015658:HIV Infections / Q000188:drug therapy*; D019259:Lamivudine / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine